The pharmaceutical market is changing rapidly. Markets are getting smaller and the advanced pace of drug development and approval has begun to fragment markets of all sizes. In this environment, the role of the pharmaceutical representative is facing new challenges.
Traditionally, pharmaceutical sales representatives have been valued highly for the information they provide during face-to-face encounters and the access to information they enable through conference symposia, luncheons and dinners, diagnostic and treatment aids and company databases. However, the rapid pace of change of the pharmaceutical market calls into question the effectiveness of traditional methods of deploying and directing sales teams and other marketing initiatives.
In this white paper, our experts examine how advances in segmentation and targeting methods can help biopharmaceutical companies cut through the complexity and deploy teams and other marketing investments against physicians and patients who will benefit most.
Download the full report below.
